Respionix Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.05 M
- Revenue Growth 61.33%
- Profit Growth 171.11%
- Ebitda 15.08%
- Net Worth 789.04%
- Total Assets 13.37%
About Respionix Healthcare
Respionix Healthcare Private Limited (RHPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 2018 (Six years and ten months 3 days old ). Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.05 M.
Bijay Kumar and Chandan Das serve as directors at the Company.
Company Details
- Location
Khorda, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52609OR2018PTC028752
- Company No.
028752
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Respionix Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandan Das  | Director | 24-Apr-2018 | Current |
| Bijay Kumar | Director | 24-Apr-2018 | Current |
Financial Performance of Respionix Healthcare.
Respionix Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 61.33% increase. The company also saw a substantial improvement in profitability, with a 171.11% increase in profit. The company's net worth Soared by an impressive increase of 789.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Respionix Healthcare?
Unlock access to Respionix Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.05 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2024 | Hdfc Bank Limited | ₹1.04 M | Open |
| 25 Aug 2023 | Hdfc Bank Limited | ₹1.01 M | Open |
How Many Employees Work at Respionix Healthcare?
Unlock and access historical data on people associated with Respionix Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Respionix Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Respionix Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.